(3'S,1S,2S,3R,6S)-2-(3'-HYDROXY-3'-CYClOHEXYLPROP-1'-YNYL]-3-HYDROXY-8-ENDO-METHYLBICYClO-[4.2.0]-OCTANE-7-ONE
Compound with spectra: 1 NMR
![(3'S,1S,2S,3R,6S)-2-(3'-HYDROXY-3'-CYClOHEXYLPROP-1'-YNYL]-3-HYDROXY-8-ENDO-METHYLBICYClO-[4.2.0]-OCTANE-7-ONE](/api/compound/BazOa5Ppt0o.png?ph=true&h=300&w=458 "(3'S,1S,2S,3R,6S)-2-(3'-HYDROXY-3'-CYClOHEXYLPROP-1'-YNYL]-3-HYDROXY-8-ENDO-METHYLBICYClO-[4.2.0]-OCTANE-7-ONE")
| SpectraBase Compound ID | BazOa5Ppt0o |
|---|---|
| InChI | InChI=1S/C18H26O3/c1-11-17-13(16(20)10-8-14(17)18(11)21)7-9-15(19)12-5-3-2-4-6-12/h11-17,19-20H,2-6,8,10H2,1H3/t11-,13+,14+,15+,16-,17-/m0/s1 |
| InChIKey | BVIVHMIFZZLGAD-FCTGFMJPSA-N |
| Mol Weight | 290.4 g/mol |
| Molecular Formula | C18H26O3 |
| Exact Mass | 290.188195 g/mol |
| Enantiomer InChIKey | BVIVHMIFZZLGAD-QAYFICHLSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(3'S,1S,2S,3R,6S)-2-(3'-HYDROXY-3'-CYClOHEXYLPROP-1'-YNYL]-3-HYDROXY-8-EXO-METHYLBICYClO-[4.2.0]-OCTANE-7-ONE
(1S,2R,3R,6S,8R)-2-[(3S)-3-cyclohexyl-3-hydroxyprop-1-ynyl]-3-hydroxy-8-methylbicyclo[4.2.0]octan-7-one
(3'S,1R,2R,3S,6R)-2-(3'-HYDROXY-3'-CYClOHEXYLPROP-1'-YNYL]-3-HYDROXY-8-ENDO-METHYLBICYClO-[4.2.0]-OCTANE-7-ONE
(3'S,1R,2R,3S,6R)-2-(3'-HYDROXY-3'-CYClOHEXYLPROP-1'-YNYL]-3-HYDROXY-8-EXO-METHYLBICYClO-[4.2.0]-OCTANE-7-ONE
(5E)-9A-DEOXA-13,14-DEHYDRO-1A,20A-DIHOMOPROSTAGLANDIN I2
(5Z)-9A-DEOXA-13,14-DEHYDRO-1A,20A-DIHOMOPROSTAGLANDIN I2
(5E)-9A-DEOXA-13,14-DEHYDROPROSTAGLANDIN I2
(5Z)-9A-DEOXA-13,14-DEHYDROPROSTAGLANDIN I2
(5E)-9A-DEOXA-13,14-DEHYDRO-20A-HOMOPROSTAGLANDIN I2
(5Z)-9A-DEOXA-13,14-DEHYDRO-20A-HOMOPROSTAGLANDIN I2
| Title | Journal or Book | Year |
|---|---|---|
| Stereochemical Consequences of 6- and 8-Substitution in Reactions of Bicyclo[4.2.0]octan-7-ones | The Journal of Organic Chemistry | 1994 |